A Novel Serum Biomarker Model to Discriminate Aortic Dissection from Coronary Artery Disease

Figure 2

Receiver operating characteristic curves for biomarkers according to the time from symptom onset. (a) Single factor between AD and CAD in the discovery set. (b) FLUTHE between AD and CAD patients of the discovery set in all-time intervals. (c) FLUTHE between AD and non-AD disease patients of the discovery set in all-time intervals. (d) FLUTHE between AD and CAD patients in the discovery set within the first 72 h from symptom onset. (e) FLUTHE between AD and CAD patients in the discovery set over the first 72 h from symptom onset. (f) FLUTHE between AD and non-AD patients in the discovery set within the first 72 h from symptom onset. (g) FLUTHE between AD and non-AD patients in the discovery set over the first 72 h from symptom onset. AD: aortic dissection; CAD: coronary artery disease; sFe: serum iron; TF: transferrin; TIBC: total iron-binding capacity.

(a)

(b)

(c)

(d)

(e)

(f)

(g)